300210 (Harmonized System 1992 for 6-digit)

About

Overview This page contains the latest trade data of Antisera and other blood fractions. In 2021, Antisera and other blood fractions were the world's 10th most traded product, with a total trade of $200B. Between 2020 and 2021 the exports of Antisera and other blood fractions grew by 16.6%, from $172B to $200B. Trade in Antisera and other blood fractions represent 0.95% of total world trade.

Antisera and other blood fractions are a part of Vaccines, blood, antisera, toxins and cultures.

Exports In 2021 the top exporters of Antisera and other blood fractions  were Switzerland ($33.5B), Germany ($32.4B), Ireland ($27.2B), United States ($27.1B), and Netherlands ($11.5B).

Imports In 2021 the top importers of Antisera and other blood fractions were United States ($42.4B), Germany ($29.9B), Switzerland ($10.4B), China ($9.26B), and Japan ($8.8B).

Ranking Antisera and other blood fractions ranks 211th in the Product Complexity Index (PCI).

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Antisera and other blood fractions. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2021)Switzerland$33.5B
Top Destination (2021)United States$42.4B

In 2021 Antisera and other blood fractions were the world's 10th most traded product (out of 4,641).

In 2021, the top exporters of Antisera and other blood fractions were Switzerland ($33.5B), Germany ($32.4B), Ireland ($27.2B), United States ($27.1B), and Netherlands ($11.5B).

In 2021, the top importers of Antisera and other blood fractions were United States ($42.4B), Germany ($29.9B), Switzerland ($10.4B), China ($9.26B), and Japan ($8.8B).

Explore Visualizations

Exporters of Antisera and other blood fractions (2021)
[Click to Select a Country]

Importers of Antisera and other blood fractions (2021)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2020 -  2021)China$6.72B
Top Destination Growth (2020 -  2021)United States$8.07B

Between 2020 and 2021, the exports of Antisera and other blood fractions grew the fastest in China ($6.72B), Netherlands ($3.62B), Ireland ($3.59B), Switzerland ($3.46B), and United States ($2.42B).

Between 2020 and 2021, the fastest growing importers of Antisera and other blood fractions were United States ($8.07B), Germany ($7.06B), United Kingdom ($2.7B), France ($2.25B), and China ($2.16B).

Explore Visualizations

Exporters of Antisera and other blood fractions (2020 - 2021)

Importers of Antisera and other blood fractions (2020 - 2021)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Antisera and other blood fractions.

In 2021, market concentration measured using Shannon Entropy, was 3.76. This means that most of the exports of Antisera and other blood fractions are explained by 13 countries.

Explore Visualizations

Value of Exports in Antisera and other blood fractions

Net Trade

TOP NET EXPORTER (2021)Ireland$23.6B
TOP NET IMPORTER (2021)United States$15.3B

This map shows which countries export or import more of Antisera and other blood fractions. Each country is colored based on the difference in exports and imports of Antisera and other blood fractions during 2021.

In 2021, the countries that had a largest trade value in exports than in imports of Antisera and other blood fractions were Ireland ($23.6B), Switzerland ($23.1B), South Korea ($5.07B), Netherlands ($3.45B), and Singapore ($3.13B).

In 2021, the countries that had a largest trade value in imports than in exports of Antisera and other blood fractions were United States ($15.3B), Japan ($5.44B), France ($5.04B), Canada ($4.37B), and United Kingdom ($3.63B).

Net Trade (2021)

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Antisera and other blood fractions.
It is possible to select the main countries that export or import Antisera and other blood fractions in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Antisera and other blood fractions by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2021)

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with